CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
Period EndCash from operations (Million JPY)YoY (%)
Jun 30, 2025-771-39.74%
Jun 30, 2024-1,280-8.49%
Jun 30, 2023-1,399+94.35%
Jun 30, 2022-720+4.54%
Jun 30, 2021-689+24.53%
Jun 30, 2020-553+44.11%
Jun 30, 2019-384-10.66%
Jun 30, 2018-429+37.15%
Jun 30, 2017-313-24.96%
Jun 30, 2016-417+34.81%
Jun 30, 2015-310+23.61%
Jun 30, 2014-250
AI Chat